❌

Normal view

Received — 7 October 2026 ⏭

Authors’ Reply: Clarifying the Comparative Interpretation and Clinical Implications of Radiomics-Based AI for Pathological Response Prediction

✇Journal of Medical Internet Research
By: Ziqi Jiang · Yuan Xu · Shuyu Jia · Hongsheng Liu
7 October 2026 at 02:45
This author reply responds to a Letter to the Editor commenting on our systematic review and meta‑analysis evaluating radiomics‑based artificial intelligence for predicting pathological response following neoadjuvant immunochemotherapy in non‑small‑cell lung cancer. We clarify several methodological points raised in the comment, including patient versus assessment counts in a cited study, cross‑study versus within‑patient comparisons of diagnostic metrics, and the sensitivity‑specificity trade‑off between artificial‑intelligence models and conventional response criteria (RECIST 1.1, PERCIST). We acknowledge two textual errors in the original discussion and confirm they do not affect primary pooled analyses. We further elaborate on eligibility constraints, heterogeneity across prediction time points, definitions of pathological complete response, and reporting standards such as DECIDE‑AI. Our core conclusion remains unchanged: radiomics‑based artificial intelligence shows promising predictive performance with a potential sensitivity advantage over RECIST 1.1, though definitive evidence requires prospective same‑patient, same‑time‑point validation studies.

Spatial, single-nucleus and pathological profiling of the invasive front in early hepatocellular carcinoma for characterizing specific leading-edge cell niche and improving recurrence modeling

✇Omics in Hepatocellular
By: Xicheng Wang · Xiaolan Mu · Yong Fu · Wei Dong · Wenfeng Lu · Xiuhua Li · Yanxiang Song · Changcheng Liu · Baoju Hou · Haibin Zhang · Xiong Chen · Yongchao Cai · Zhiying He
29 September 2026 at 18:00

Int J Biol Sci. 2026 Sep 10;22(14):8090-8118. doi: 10.7150/ijbs.137262. eCollection 2026.

ABSTRACT

The tumor leading edge (TLE) is a critical region where tumor cells interact with the microenvironment to drive invasion and metastasis; however, its cellular architecture in early hepatocellular carcinoma (HCC) remains poorly understood. Here, we integrated single-nucleus RNA-seq (snRNA-seq), spatial transcriptomics, and computational pathology to investigate TLE in early HCC. We annotated 35 cell subpopulations and identified STMN1-high tumor cells as a key malignant subset enriched at the invasive front, interacting with Treg, plasma B, LAMP3⁺ dendritic cells and SPP1⁺ macrophages. Spatial analysis revealed three co-localized cell pairs-(SPP1⁺ macrophages co-localized with Tip-like and inflammatory endothelial cells), (LAMP3⁺ DCs co-localized with naive T cells), and (plasma B cells co-localized with cancer-associated fibroblasts)-forming a leading-edge tumor microenvironment (L-TME) niche associated with early relapse. We developed an L-TME-related machine-learning benchmark framework incorporating 71 imaging features (65 deep-learning + 6 pathological) based on the snRNA-seq, spatial transcriptomics and pathomics. The pathology model achieved robust performance (mean C-index=0.77) and successfully predicted the recurrence of early HCC (log-rank p < 0.05) in TCGA (n=147) and an independent in-house cohort (n=123). This study delineates the TLE cellular ecosystem of early HCC, defines a spatially coordinated immunosuppressive L-TME niche, and provides a clinically applicable predictive tool for postoperative recurrence. Integrating multi-omics with computational pathology deepens our understanding of early HCC metastasis and offers insights into improved prognostication and therapeutic strategies.

PMID:42807944 | PMC:PMC13618224 | DOI:10.7150/ijbs.137262

Transketolase-like 1 potentiates PD-1 blockade in hepatocellular carcinoma by glycolysis to prime dendritic cell lactylation

✇Omics in Hepatocellular
By: Hengsong Cao · Tian Huang · Yue Chai · Zhengqing Lu · Shipeng Dai · Danyang Xu · Yanshu He · Na Yu · Yuliang Wang · Ziyuan Liu · Yidong Xia · Jie Zhao · Hongyu Wang · Dawei Rong · Yuchen Xie · Chongyu Wang · Pengyu Chen · Juyue Zhou · Li Liu · Zhuozheng Li · Hanyuan Liu · Xiao Li · Xuehao Wang · Weiwei Tang · Yongxiang Xia
27 September 2026 at 18:00

Signal Transduct Target Ther. 2026 Sep 28;11(1):418. doi: 10.1038/s41392-026-02875-2.

ABSTRACT

Hepatocellular carcinoma (HCC) exhibits a suboptimal response to immune checkpoint blockade (ICB) therapy; to overcome this resistance, we aimed to delineate key immune resistance factors via multi-omics analysis, develop strategies to block their immunosuppressive axes, and engineer a targeted nanosystem to enhance immunotherapy efficacy against PD-1 resistance in HCC. Using transcriptomic and proteomic data from anti-PD-1-treated HCC patients, along with functional validation in murine models and mechanistic molecular and cell biology studies, we identified transketolase-like 1 (TKTL1) as a dual-nature biomarker where overexpression predicted poor baseline prognosis yet enhanced response to ICB. Mechanistically, TKTL1 diverts glucose flux into glycolysis rather than pentose phosphate pathway (PPP), recruiting USP9X to deubiquitinate and stabilize HIF-1α, which upregulates HK2 to amplify glycolytic output and lactate accumulation. This metabolic rewiring orchestrates dual immunosuppressive circuits through HIF-1α-driven CCL4 secretion recruiting PD-L1high dendritic cells (DCs), coupled with lactate-induced TRIM28K408 lactylation that stabilizes PD-L1 by blocking ubiquitin-mediated degradation. We engineered a hepatoma-membrane-coated MnO₂ nanosystem (CQLH) co-delivering a TKTL1 inhibitor and lactate oxidase, which disrupted the TKTL1-HIF-1α-HK2 axis, depleted lactate, and reprogrammed the tumor microenvironment, thereby enhanced anti-PD-1 therapy to suppress tumor growth, especially in TKTL1high tumors. These findings define a critical "TKTL1-glycolysis-lactate-DC" axis driving anti-PD-1 sensitivity in HCC, position TKTL1 as both a potential biomarker for ICB response and a tractable therapeutic target, and demonstrate that the targeted CQLH nanosystem overcomes resistance and enhances anti-PD-1 efficacy, offering a precision immunotherapeutic strategy for TKTL1high HCC.

PMID:42802226 | PMC:PMC13616917 | DOI:10.1038/s41392-026-02875-2

Received — 15 September 2026 ⏭

Occamy-1.0: Open Pareto-frontier 35B Intelligence for Co-work

✇cs.AI, q-bio.NC updates on arXiv.org
By: Wenhui Chen · Shiwen Cheng · Hao Dong · Chenda Duan · Ruixiang Feng · Zhong Guan · Boqiang Guo · Xueyuan Han · Haojie Hao · Liangmeng Huang · Zhelong Huang · Xinke Kong · Hongyu Li · Jiazheng Li · Junbo Li · Qingchuan Li · Yukun Lian · Chang Liu · Tianyu Liu · Zicheng Liu · Shuyi Ouyang · Yijun Pan · Kunyu Shi · Xiaojun Tang · Bingquan Wang · Kesu Wang · Yuchen Wang · Sibo Wei · Sicong Xie · Xiaoying Xing · Yi Xu · Zhijun Xu · Hongwei Xue · Qingcheng Zeng · Di Zhang · Guannan Zhang · Haochen Zhang · Tianlong Zhang · Tianyu Zhao · Tianyu Zhao · Yanjun Zheng · Jialong Zhu · Zijian Zou
14 September 2026 at 12:00
arXiv:2609.11977v1 Announce Type: new Abstract: Co-work agents execute complex workflows that combine information gathering, tool use, coding, and file manipulation across many model invocations. Because cost and latency accumulate over the full episode, their practical value depends not only on peak capability but also on how efficiently that capability is delivered. Yet many steps in everyday work emphasize state tracking, coordination, recovery, and follow-through rather than frontier-scale reasoning. We present Occamy-1.0, a cost-efficient co-work model obtained by further training the post-trained Qwen3.6-35B-A3B checkpoint. We construct execution-grounded data and environments, capture replayable long-horizon trajectories across multiple harnesses, and use staged post-training to develop and consolidate complementary execution capabilities. Across a broad suite of co-work benchmarks, Occamy-1.0 is consistently among the strongest comparably sized models and remains competitive with substantially larger frontier systems on several tasks. Under our stated evaluation and pricing protocol, its aggregate performance across four representative benchmarks places it at the low-cost knee of the observed cost--performance Pareto frontier. Supporting evaluations in tool calling, coding, and instruction following further show that this specialization preserves broad agentic capability. We release the model weights and a subset of the training data to support research on practical co-work agents and agentic post-training.

AsyncFlow: An Asynchronous Streaming RL Framework for Efficient LLM Post-Training

✇cs.AI, q-bio.NC updates on arXiv.org
By: Zhenyu Han · Ansheng You · Haibo Wang · Kui Luo · Guang Yang · Wenqi Shi · Menglong Chen · Sicheng Zhang · Zeshun Lan · Chunshi Deng · Huazhong Ji · Wenjie Liu · Yu Huang · Yixiang Zhang · Chenyi Pan · Jing Wang · Xin Huang · Chunsheng Li · Jianping Wu
14 September 2026 at 12:00
arXiv:2507.01663v2 Announce Type: replace-cross Abstract: Reinforcement learning (RL) has become a pivotal technology in the post-training phase of large language models (LLMs). Traditional task-collocated RL frameworks suffer from significant scalability bottlenecks, while task-separated RL frameworks face challenges in managing complex dataflows and resolving resource idling. Furthermore, most existing frameworks are tightly coupled with LLM training or inference engines, making them difficult to support custom-designed engines. To address these challenges, we propose AsyncFlow, an asynchronous streaming RL framework tailored for efficient post-training. Specifically, we introduce a distributed data storage and transfer module that provides panoramic data management and fine-grained scheduling capabilities in a fully streamed manner. This architecture inherently enables automated pipeline overlapping among RL tasks and dynamic load-balancing. Moreover, we propose an asynchronous producer-consumer workflow, which is engineered to minimize computational idleness by strategically deferring the parameter update process within staleness thresholds. Finally, the core capabilities of AsyncFlow are architecturally decoupled from underlying training and inference engines and encapsulated by service-oriented user interfaces, offering a modular and customizable user experience. Extensive experiments demonstrate an average throughput of 1.59x compared to the state-of-the-art baseline. The architecture presented in this work provides actionable insights for designing next-generation RL training systems.

Dynamic Expert Quantization for Scalable Mixture-of-Experts Inference

✇cs.AI, q-bio.NC updates on arXiv.org
By: Kexin Chu · Dawei Xiang · Zixu Shen · Yiwei Yang · Zecheng Liu · Wei Zhang
14 September 2026 at 12:00
arXiv:2511.15015v4 Announce Type: replace-cross Abstract: Mixture-of-Experts (MoE) has become a practical architecture for scaling LLM capacity while keeping per-token compute modest, but deploying MoE models on a single, memory-limited GPU remains difficult because expert weights dominate the HBM footprint. Existing expert offloading and prefetching systems reduce the resident set, yet they often pay expert-loading costs on the critical path when activation becomes dense. Post-training quantization (PTQ) lowers the footprint without transfers, but prevailing pipelines fix expert bit-widths offline and assume routing remains stable, even though MoE expert utilization is heavy-tailed and the hot set can shift across workloads. We present DynaExq, a runtime-aware mixed-precision serving system that treats single-GPU MoE inference under a hard HBM envelope as an online, budget-constrained precision allocation problem. The key insight is to keep the experts that dominate runtime traffic resident at higher precision, while maintaining a low-precision fallback for the remaining experts, so the system can reduce transfer volume and avoid the waiting latency that limits offloading and prefetching under dense activation. DynaExq estimates long-horizon expert hotness from router traces, selects a per-layer high-precision resident set via a budget-feasible top-$n$ rule, and applies promotions and demotions asynchronously through stable expert handles so the forward pass always executes on a fully materialized expert version. Across Qwen3-MoE-30B/80B and six benchmarks, DynaExq improves accuracy over static PTQ on Qwen3-80B (73.09% to 77.57%) under comparable device-memory budgets and achieves up to 2.73x higher throughput than offloading/prefetch baselines at batch size 32.

An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides

✇Nature Biotechnology - Issue - nature.com science feeds
By: Lang Yao · Zixuan Wang · Jialu Chen · Wen Sun · Kefan Wang · Yunqi Xiao · Hanhan Zhang · Wenzheng Li · Yifan Wang · Lulu Zhao · Xinyi Dai · Lu Qian · Panke Zhang · Shuo Huang
14 September 2026 at 08:00

Nature Biotechnology, Published online: 14 September 2026; doi:10.1038/s41587-026-03308-9

Modified nanopore simultaneously identifies diverse biomolecules and their modifications.

Advanced and underlying therapeutic strategies in transformed small cell lung cancer

✇Omics In Lung
By: Mingfeng Wei · Zheng Li · Kaiyuan Zhu · Shixiang Guo · Lefei Hu · Fuzhi Yang · Xiaoyu Chen · Xuelin Zhang · Shuai Jiang · Xunxia Zhu · Xiaoyong Shen
11 September 2026 at 18:00

Front Med (Lausanne). 2026 Aug 27;13:1865050. doi: 10.3389/fmed.2026.1865050. eCollection 2026.

ABSTRACT

Transformed small-cell lung cancer (T-SCLC) is a clinically important form of histologic transformation and a mechanism of acquired resistance in non-small-cell lung cancer (NSCLC). It is associated with poor prognosis, with a median overall survival of only about 9-13 months. This review summarizes recent advances in the mechanisms, diagnosis, monitoring, and treatment of T-SCLC. Repeat biopsy remains the gold standard for confirming histologic transformation, whereas molecular profiling and liquid biopsy may facilitate early detection and longitudinal disease monitoring. Platinum-etoposide remains the most commonly used clinical standard after transformation, but its benefit is typically transient and durable disease control remains uncommon. Continuation of EGFR tyrosine kinase inhibitors combined with chemotherapy may prolong progression-free survival in selected patients but has not consistently improved overall survival. Anti-angiogenic therapy, particularly anlotinib, and chemo-immunotherapy have shown encouraging activity in selected patients, while emerging strategies targeting DLL3, MYC, SOX2, and epigenetic regulators may broaden the therapeutic landscape. Prospective studies integrating repeat tissue sampling, comprehensive genomic profiling, biomarker-guided patient stratification, pharmacogenomics, functional drug-sensitivity testing where feasible, and integrated multi-omics approaches are needed to advance molecularly guided and individualized treatment for T-SCLC.

PMID:42724635 | PMC:PMC13560167 | DOI:10.3389/fmed.2026.1865050

Received — 13 September 2026 ⏭

Advanced and underlying therapeutic strategies in transformed small cell lung cancer

✇(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
By: Mingfeng Wei · Zheng Li · Kaiyuan Zhu · Shixiang Guo · Lefei Hu · Fuzhi Yang · Xiaoyu Chen · Xuelin Zhang · Shuai Jiang · Xunxia Zhu · Xiaoyong Shen
11 September 2026 at 18:00

Front Med (Lausanne). 2026 Aug 27;13:1865050. doi: 10.3389/fmed.2026.1865050. eCollection 2026.

ABSTRACT

Transformed small-cell lung cancer (T-SCLC) is a clinically important form of histologic transformation and a mechanism of acquired resistance in non-small-cell lung cancer (NSCLC). It is associated with poor prognosis, with a median overall survival of only about 9-13 months. This review summarizes recent advances in the mechanisms, diagnosis, monitoring, and treatment of T-SCLC. Repeat biopsy remains the gold standard for confirming histologic transformation, whereas molecular profiling and liquid biopsy may facilitate early detection and longitudinal disease monitoring. Platinum-etoposide remains the most commonly used clinical standard after transformation, but its benefit is typically transient and durable disease control remains uncommon. Continuation of EGFR tyrosine kinase inhibitors combined with chemotherapy may prolong progression-free survival in selected patients but has not consistently improved overall survival. Anti-angiogenic therapy, particularly anlotinib, and chemo-immunotherapy have shown encouraging activity in selected patients, while emerging strategies targeting DLL3, MYC, SOX2, and epigenetic regulators may broaden the therapeutic landscape. Prospective studies integrating repeat tissue sampling, comprehensive genomic profiling, biomarker-guided patient stratification, pharmacogenomics, functional drug-sensitivity testing where feasible, and integrated multi-omics approaches are needed to advance molecularly guided and individualized treatment for T-SCLC.

PMID:42724635 | PMC:PMC13560167 | DOI:10.3389/fmed.2026.1865050

Baseline cellular state shapes the molecular impact of mutant KRAS alleles in reconstituted pancreatic cancer cells

✇(Multiomics OR Omics) AND (Pancreatic)
By: Yanixa Quiñones-Avilés · Barbora Salovska · Cassandra S Markham · Yi Di · Benjamin E Turk · Yansheng Liu · Mandar Deepak Muzumdar
10 September 2026 at 18:00

Mol Omics. 2026 Sep 10:aaiag022. doi: 10.1093/molecular-omics/aaiag022. Online ahead of print.

ABSTRACT

KRAS is mutated in over 90% of pancreatic ductal adenocarcinomas (PDAC), where hotspot alterations in codons 12, 13, and 61 drive tumor initiation and progression. Although distinct biochemical properties have been described for individual KRAS mutants, whether they generate unique allele-specific signaling programs in PDAC cells remains unresolved. Here, we systematically interrogated the molecular consequences of seven common KRAS mutant variants in reconstituted isogenic, KRAS-deficient PDAC cell lines by integrated transcriptomic, proteomic, and phosphoproteomic profiling. We found that baseline cellular state, rather than allele identity, was the predominant driver of molecular variation. Comparisons with established KRAS reference signatures revealed significant but moderate overlap at the mRNA level and less so at the proteome level. Pathway analyses highlighted interferon response and mitochondrial translation-related proteins as recurrently altered across mutant alleles, while phosphoproteomic data confirmed robust ERK1/2 activity and suppression of DYRK kinase substrates by mutant KRAS expression. Importantly, no robust mutant allele-specific molecular programs were identified in our KRAS-reconstituted cell lines. Together, our study establishes a comprehensive multi-omics resource for KRAS signaling in PDAC and demonstrates that cellular context exerts a stronger influence than allele identity in shaping molecular profiles, with implications for interpreting putative allele-specific signaling dependencies.

PMID:42720273 | DOI:10.1093/molecular-omics/aaiag022

Impact of LLM-supported patient education on patient perspectives and patient-reported outcomes: a mixed-methods systematic review

✇npj Digital Medicine
By: Jiayi Liu · Yanan Zhang · Honghao Lai · Min Han · Ning Ma · Sibo Du · Weilong Zhao · Danni Xia · Bo Tong · Yanru Liu · Bei Pan · Xiaoman Wang · Bingyi Wang · Xufei Luo · Yimeng Li · Janne Estill · Sheng Li · Hongfei Cui · Li Xiao · Long Ge
10 September 2026 at 08:00

npj Digital Medicine, Published online: 10 September 2026; doi:10.1038/s41746-026-03228-7

Impact of LLM-supported patient education on patient perspectives and patient-reported outcomes: a mixed-methods systematic review
Received — 10 September 2026 ⏭

Targeting the MNK1-MYH9 axis blocks YAP1 recruitment to prevent thrombosis and platelet activation-induced NETosis

✇Molecular Therapy
By: Kang Liu · Xinke Fang · Jingjun Sheng · Zhiming Wang · Ruijuan Yin · Qi Yuan · Tianyu Wang · Shaoyun Zhou · Qisheng Ling · Haidong Chen · Muhammad Awais · Tao Jiang · Chuanbin Shen
3 August 2026 at 08:00
MNK1 acts as a structural shield on MYH9, preventing YAP1-mediated platelet activation. Developing MD2 to lock this MNK1-MYH9 complex introduces a safe antithrombotic strategy, shifting the therapeutic paradigm from kinase inhibition to stabilizing protein-protein interactions against immunothrombosis.

Switchable single-atom catalysts for highly selective C–C coupling in direct methane oxidation

✇Nature Nanotechnology
By: Xiao Han · Peixin Cui · Geng Wu · Jinyan Cai · Chao Wang · Fanfei Sun · Panzhe Qiao · Xiaocheng Liu · Jiahao Zhuang · Huan Liu · Fabing Su · Gongming Wang · Wensheng Yan · Zeming Qi · Yue Lin · Xun Hong · Yadong Li
7 September 2026 at 08:00

Nature Nanotechnology, Published online: 07 September 2026; doi:10.1038/s41565-026-02271-5

Single copper atoms on boron nanosheets dynamically and reversibly switch to clusters, enabling the direct conversion of methane to acetic acid with 97% selectivity and high activity without the requirement for carbon monoxide.

PACE: Perceived-Latency-Aware Cascading Service Routing and Filler Control for QoE-Efficient Retrieval-Augmented Dialogue Serving

✇cs.AI, q-bio.NC updates on arXiv.org
By: Lin Huang · Yujuan Tan · Weisheng Li · Lixiang Zeng · Kun Yang · Suihan Xiao
10 September 2026 at 12:00
arXiv:2609.10372v1 Announce Type: cross Abstract: We present the PACE, a framework for retrieval-augmented dialogue serving that formalizes Perceived Time-to-First-Response (PTFR) as a QoE objective and minimizes it under quality/cost constraints. Unlike prior work on cascaded routing, semantic caching, or adaptive retrieval, PACE jointly controls which answer source composes the response and what fills the waiting window. Deployed on a humanoid-robot sales service, it combines three mechanisms: a load-adaptive cascading router, a joint path-filler controller, and volatility-aware cache admission. On 75k CarQA requests, the cascade halves pure-LLM PTFR at P95 (0.29 vs 0.53s at c16). The adaptive controller reaches 0.41s P95, outperforming RAG by 2.4 times at high load with equal quality. The filler controller cuts calls by 94% with zero conflict. Volatility-aware admission reduces stale answers from 86% to 0%. A gating rule ensures the controller never worse than the baseline, with exposure bounded by one hold period. This is the first quantification of filler-answer conflict risk in deployed services.

EvolveScaler: Synthesizing Information-Evolution Contexts via Executable State Machines and Natural-Language Rendering

✇cs.AI, q-bio.NC updates on arXiv.org
By: Ziliang Zhao · Zenan Xu · Shuting Wang · Zhao Wang · Bowen Cao · Minda Hu · Lincheng Li · Pluto Zhou · Zhicheng Dou
10 September 2026 at 12:00
arXiv:2609.08435v2 Announce Type: replace Abstract: In persistent interactions, long contexts may encode an evolving process rather than a fixed record: later events can revise or revoke earlier information, changing what remains valid and what conclusions follow. We call this setting information evolution (IE). Solving IE requires identifying valid records, applying updates in order, and reconstructing the query-relevant state from the event history. Existing text-first synthesis pipelines make such data difficult to verify because state transitions and answer logic remain implicit. We introduce EvolveScaler, a code-driven framework that defines information evolution before rendering it as natural language. Human-authored operational specifications define state transitions, record validity, difficulty controls, and executable answer logic; a strong LLM then synthesizes a self-contained simulator from each specification. Executing validated simulators produces natural-language multi-turn event histories, while deterministic replay computes reference answers and atomic checklists. We instantiate EvolveScaler with 117 task prototypes and 159 final-question operators across five difficulty levels spanning approximately 7 to 1,200 events per instance, yielding about 35,100 training examples and 585 validated evaluation instances. On the very_long tier, the strongest model reaches 59.3% avg@5, while six models score below 10%. Training an internal A3B model on 6,000 EvolveScaler examples improves performance over its base checkpoint on all eight independently constructed out-of-distribution benchmarks, with a 5.25-point average gain. These results show that code-driven IE synthesis provides both challenging evaluation and transferable training supervision.
Received — 27 May 2026 ⏭

Accelerating Long-Tail Generation in Synchronous RLHF Training via Adaptive Tensor Parallelism

✇cs.AI, q-bio.NC updates on arXiv.org
By: Long Zhao · Qinghe Wang · Jiaan Zhu · Youhui Bai · Zewen Jin · Chaoyi Ruan · Shengnan Wang · Cheng Li
26 May 2026 at 12:00
arXiv:2605.23945v1 Announce Type: new Abstract: Reinforcement Learning from Human Feedback (RLHF) has become a key post-training paradigm for improving model quality. However, the synchronous three-stage RLHF pipeline is often bottlenecked by the generation stage, where response-length skew causes the effective batch size to shrink rapidly during decoding, leaving GPUs underutilized while a few long responses remain unfinished. Mainstream frameworks employ a static tensor parallelism (TP) configuration that cannot adapt to changing batch characteristics, leaving substantial performance headroom unexplored. We propose PAT, an adaptive TP method that dynamically reconfigures TP during the generation stage of each RLHF iteration. PAT introduces two key techniques. First, a predictor-guided online reconfiguration method decides both the reconfiguration point and the target TP configuration based on offline profiling, triggering reconfiguration only when the predicted latency benefit outweighs the reconfiguration overhead. Second, a lightweight online reconfiguration mechanism updates only the states and layouts affected by TP changes: it adapts unfinished decoding states through a cost-model-based choice between KV-cache migration and recomputation, performs in-place weight resharding, and reuses cached communication groups. We implement PAT on top of SGLang and integrate it with the VeRL framework. Evaluations on LLaMA3.1-8B and Qwen3-14B using DeepScaleR show that PAT reduces generation latency by up to 34.6% and end-to-end RLHF training iteration latency by up to 27.2% compared to the original VeRL setup.

SAM: State-Adaptive Memory for Long-Horizon Reasoning Agent

✇cs.AI, q-bio.NC updates on arXiv.org
By: Yuyang Hu · Hongjin Qian · Shuting Wang · Jiongnan Liu · Ziliang Zhao · Jiejun Tan · Zheng Liu · Zhicheng Dou
26 May 2026 at 12:00
arXiv:2605.24468v1 Announce Type: new Abstract: Long-horizon agentic reasoning requires large language models to act over long interaction histories containing thoughts, tool calls, observations, and partial conclusions. The challenge is not merely that these histories grow long, but that information needed for the current decision may be scattered across distant steps and only become relevant later. Existing approaches address this difficulty by truncating the interaction history, compressing it into shorter surrogates, or retrieving selected parts of it for reuse, but they do not explicitly model how access to past interaction should adapt to the agent's evolving state. We instead cast long-horizon reasoning as a problem of state-adaptive memory. To this end, we propose State-Adaptive Memory~(SAM), a standalone framework that consolidates ongoing interaction into compact memory cues while preserving raw trajectory pages for intent-driven recall. These cues are not treated as replacements for history; rather, they serve as lightweight handles that allow the agent to reconstruct temporally distant information according to its current needs, without retraining the underlying backbone. We further optimize the memory module through expert-guided supervision and reinforcement learning, aligning it with trajectory-level utility. Across BrowseComp, BrowseComp-ZH, WideSearch, and HLE, SAM consistently outperforms strong baselines over diverse agent backbones. Our results suggest that explicit memory modeling provides a simple and effective foundation for long-horizon agentic reasoning.

AgentFugue: Agent Scaling for Long-Horizon Tasks through Collective Reasoning

✇cs.AI, q-bio.NC updates on arXiv.org
By: Yuyang Hu · Hongjin Qian · Shuting Wang · Jiongnan Liu · Tong Zhao · Xiaoxi Li · Zheng Liu · Zhicheng Dou
26 May 2026 at 12:00
arXiv:2605.24486v1 Announce Type: new Abstract: Recent progress on long-horizon agentic tasks has been driven largely by scaling up individual agents through stronger models, better tools, and more effective scaffolding. In contrast, much less is understood about scaling out: whether multiple peer agents, all targeting the same task, can become an additional source of capability without relying on explicit role specialization or workflow orchestration. We study this question and propose AgentFugue, a collective reasoning framework built around a shared reasoning hub. As peer agents explore the same task in parallel, the hub records concise notes on what each agent has established, attempted, or ruled out, and enables each agent to selectively access what other agents have discovered in a form useful for its current search. This design turns otherwise isolated trajectories into a connected ecology of reusable intermediate reasoning without requiring centralized planning. We instantiate the hub as a plug-in communication layer, trained with supervised fine-tuning and end-to-end reinforcement learning. Across the challenging long-horizon settings we study, AgentFugue improves over strong baselines. Our results suggest that collective reasoning can turn scaling out peer agent systems into a distinct source of capability gains, rather than merely a way of spending more compute.

Hera: Learning Long-Horizon Coordination for Device-Cloud Collaborative LLM Agents

✇cs.AI, q-bio.NC updates on arXiv.org
By: Yuxin Zhang · Mengxue Hu · Zheng Lin · Xiaoyi Fan · Fan Xie · Zihan Fang · Jing Yang · Wenjun Zhu · Zhiwen Chen · Chengfei Lv · Zhe Chen
26 May 2026 at 12:00
arXiv:2605.24598v1 Announce Type: new Abstract: Large language model (LLM) agents excel at solving complex long-horizon tasks through autonomous interaction with environments. However, their real-world deployment faces a fundamental device--cloud dilemma: on-device models are efficient but often brittle, while cloud models are stronger but costly in computation. State-of-the-art LLM device--cloud routers usually make coarse task-level decisions, which cannot adapt to the changing difficulty of multi-step agent interactions. To address this issue, we present Hera, a step-level device--cloud LLM agent coordinator for long-horizon tasks achieving a strong performance--cost Pareto frontier. Hera adopts a novel two-stage training paradigm: (1) imitation learning for cold-start, followed by (2) reinforcement learning that jointly optimizes task success and cloud usage efficiency. The first stage casts step-level routing as a supervised classification problem: the device agent is replayed on cloud trajectories, with each state labeled by the agreement between device and cloud actions. In the second stage, we perform cost-aware reinforcement learning by grouping identical states across trajectories and updating Hera with labels favoring higher expected return and fewer future cloud calls. We evaluate Hera on ALFWorld, WebShop, and AppWorld, where it consistently outperforms prior methods, achieving 92.5% of the cloud-only success rate with cloud use in only 46.3% of steps.
❌